Longevity Health 

$0.005300
0
+$0.00+0% Friday 19:07

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0.0053
Volume
16,099
Avg. Volume
-
Mkt Cap
9,444.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-360.95%Profit Margin
Unprofitable
2021
2022
2023
2024
2025
1.91MRevenue
-6.91MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the medical devices sector, directly competing with Carmell in the development and manufacturing of innovative biomedical products.
Stryker
SYK
Mkt Cap126.84B
Stryker specializes in medical technologies, including orthopedic products, which overlap with Carmell's focus on bone healing technologies.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare market, directly relevant to Carmell's bone and tissue healing products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation offers medical solutions that compete with Carmell's products in the areas of pain management and rehabilitation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those for surgical and orthopedic use.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides a wide range of medical devices and healthcare solutions that compete with Carmell's offerings in the biomedical sector.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. develops and manufactures advanced surgical systems that could be seen as alternative solutions to Carmell's regenerative products.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart and vascular health technologies, competing indirectly by offering alternative medical treatments.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a broad array of medical devices and pharmaceuticals that compete in the overall healthcare market, including areas covered by Carmell.

About

Longevity Health Holdings Inc. is dedicated to advancing plasma-derived bioactive materials (PBMs) designed to stimulate tissue regeneration and recovery following injuries, illnesses, or age-related decline. Their primary product in development, CT-101, functions both as an accelerant for bone healing—with intended uses including the repair of tibia fractures, facilitating foot and ankle fusions, aiding spinal fusions, substituting for dental bone grafts, and filling bone voids—and as a tissue healing accelerator for conditions such as androgenetic alopecia and persistent wounds. This company was established in 2008 and is based in Pittsburgh, Pennsylvania.
Show more...
CEO
Janakiram Ajjarapu
Employees
10
Country
United States
ISIN
US1429221112

Listings

0 Comments

Share your thoughts

FAQ

What is Longevity Health stock price today?
The current price of XAGEW is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Longevity Health stock price performance more closely on the chart.
What is Longevity Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Longevity Health stocks are traded under the ticker XAGEW.
What is Longevity Health market cap?
Today Longevity Health has the market capitalization of 9,444.6
What is Longevity Health revenue for the last year?
Longevity Health revenue for the last year amounts to 1.91M USD.
What is Longevity Health net income for the last year?
XAGEW net income for the last year is -6.91M USD.
How many employees does Longevity Health have?
As of September 04, 2026, the company has 10 employees.
In which sector is Longevity Health located?
Longevity Health operates in the Health & Wellness sector.
When did Longevity Health complete a stock split?
The last stock split for Longevity Health was on May 14, 2025 with a ratio of 1:30.
Where is Longevity Health headquartered?
Longevity Health is headquartered in Pittsburgh, United States.